A computerized intervention to improve timing of outpatient follow-up - A multicenter randomized trial in patients treated with warfarin

Journal of General Internal Medicine

Volumn 9, Issue 3, 1994, Pages 131-139

  Fihn, Stephan D ^a   McDonell, Mary B ^b   Vermes, Domokos ^b   Henikoff, Jorja G ^b   Martin, Donald C ^b   Callahan, Catherine M ^b   Kent, Daniel L ^b   White, Richard H ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

computers; follow up; monitoring; patient; scheduling; warfarin

Indexed keywords

WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OUTPATIENT CARE; PATIENT SCHEDULING; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING;

APPOINTMENTS AND SCHEDULES; CONTINUITY OF PATIENT CARE; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PROTHROMBIN TIME; WARFARIN;

EID: 0028314963     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/BF02600026     Document Type: Article

References (43)

1. Visit frequency for essential hypertension: observed associations
2. Variation in physician opinion about scheduling of return visits for common ambulatory care conditions
3. Patterns of ambulatory care in internal medicine
4. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study
5. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study
6. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
7. Canadian atrial fibrillation anticoagulation study
8. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
9. The effect of warfarin on mortality and reinfarction after myocardial infarction
10. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range
11. Therapeutic control of anticoagulant treatment
12. Anticoagulant control [letter]
13. Efficacy of anticoagulation in the UK [letter]
14. The role of the pharmacist in the anticoagulant clinic
15. Oral anticoagulants: a cost-effectiveness approach
16. Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio
17. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
18. Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions
19. Hemorrhagic complications of anticoagulant treatment
20. Risk factors for complications of chronic anticoagulation. A multicenter study
21. Management of anticoagulation in outpatients. Experience with an anticoagulation service in a municipal hospital setting
22. Pharmacist management of anticoagulant therapy in ambulant patients
23. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic
24. Retrospective evaluation of a pharmacist managed warfarin anticoagulation clinic
25. Evaluation of a pharmacist-managed anticoagulation clinic
26. A computer-based information system for managing patients on long-term oral anticoagulants
27. A computer program for long-term anticoagulation control
28. Digital computer-assisted warfarin therapy: comparison of two models
29. Predicting oral anticoagulant response using a pharmacodynamic model
30. Computer-assisted management of warfarin treatment
31. Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized controlled trial in a teaching hospital
32. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study
33. A model for planning optimal follow-up for outpatients on warfarin anticoagulation
34. Optimal therapeutic range for oral anticoagulants. Second ACCP-NHLBI Conference on Antithrombotic Therapy
35. Variations in medical care among small areas
36. Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures
37. Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancer
38. Evaluation of nonlinear optimization for scheduling of follow-up cystoscopy to detect recurrent bladder cancer